These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 39272987)

  • 1. Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse.
    Annadurai N; Kanmogne GD
    Cells; 2024 Aug; 13(17):. PubMed ID: 39272987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.
    Silverstein PS; Shah A; Weemhoff J; Kumar S; Singh DP; Kumar A
    Curr HIV Res; 2012 Jul; 10(5):369-83. PubMed ID: 22591361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Faceted Roles of Cocaine in Potentiation of HAND.
    Cai Y; Yang L; Callen S; Buch S
    Curr HIV Res; 2016; 14(5):412-416. PubMed ID: 27009095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine Increases CD14
    Calderon TM; Williams DW; Lopez L; Eugenin EA; Cheney L; Gaskill PJ; Veenstra M; Anastos K; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):353-370. PubMed ID: 28133717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.
    Hoefer MM; Sanchez AB; Maung R; de Rozieres CM; Catalan IC; Dowling CC; Thaney VE; Piña-Crespo J; Zhang D; Roberts AJ; Kaul M
    Exp Neurol; 2015 Jan; 263():221-34. PubMed ID: 25246228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function
    Patel S; Leibrand CR; Palasuberniam P; Couraud PO; Weksler B; Jahr FM; McClay JL; Hauser KF; McRae M
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NeuroHIV and use of addictive substances.
    Chang SL; Connaghan KP; Wei Y; Li MD
    Int Rev Neurobiol; 2014; 118():403-40. PubMed ID: 25175871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of blood-brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins.
    Sun Y; Cai M; Liang Y; Zhang Y
    J Neurovirol; 2023 Dec; 29(6):658-668. PubMed ID: 37899420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.
    Sajja RK; Rahman S; Cucullo L
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):539-54. PubMed ID: 26661236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology.
    Thompson LJ; Genovese J; Hong Z; Singh MV; Singh VB
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats.
    Li J; Zeng B; Hu X; Li Z; Zhang D; Yang G; Dai J; Zeng X
    Am J Chin Med; 2018; 46(3):551-566. PubMed ID: 29690789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder.
    Gandhi N; Saiyed ZM; Napuri J; Samikkannu T; Reddy PV; Agudelo M; Khatavkar P; Saxena SK; Nair MP
    J Neurovirol; 2010 Jul; 16(4):294-305. PubMed ID: 20624003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine toxicity and its implications during HIV-1 infection.
    Silverstein PS; Shah A; Gupte R; Liu X; Piepho RW; Kumar S; Kumar A
    J Neurovirol; 2011 Oct; 17(5):401-15. PubMed ID: 21786077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier.
    Strazza M; Pirrone V; Wigdahl B; Nonnemacher MR
    Brain Res; 2011 Jul; 1399():96-115. PubMed ID: 21641584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and viral protein effects on the blood brain barrier.
    McRae M
    Tissue Barriers; 2016; 4(1):e1143543. PubMed ID: 27141423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.
    Teodorof-Diedrich C; Spector SA
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.
    Martin-Thormeyer EM; Paul RH
    Neuropsychol Rev; 2009 Jun; 19(2):215-31. PubMed ID: 19468837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier.
    Caccuri F; Neves V; Gano L; Correia JDG; Oliveira MC; Mazzuca P; Caruso A; Castanho M
    J Virol; 2022 Jan; 96(1):e0120021. PubMed ID: 34668776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis.
    Bhargavan B; Kanmogne GD
    Mol Neurobiol; 2018 Feb; 55(2):1352-1363. PubMed ID: 28127697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.